Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study-Reference-Cited by-同舟云学术

Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study

Published:2018-01-25 Issue:1 Volume:15 Page:e1002482
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Varma Vijay R.^ORCID,Oommen Anup M.,Varma Sudhir,Casanova Ramon,An Yang,Andrews Ryan M.^ORCID,O’Brien Richard,Pletnikova Olga,Troncoso Juan C.^ORCID,Toledo Jon^ORCID,Baillie Rebecca^ORCID,Arnold Matthias^ORCID,Kastenmueller Gabi,Nho Kwangsik^ORCID,Doraiswamy P. Murali,Saykin Andrew J.^ORCID,Kaddurah-Daouk Rima,Legido-Quigley Cristina^ORCID,Thambisetty Madhav

Funder

National Institute on Aging

National Institutes of Health (US)

U.S. Department of Defense (US)

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference60 articles.

1. Recent advances in the application of metabolomics to Alzheimer's Disease;E Trushina;Biochimica et biophysica acta,2014

2. Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics;I Barba;Journal of cellular and molecular medicine,2008

3. Plasma phospholipids identify antecedent memory impairment in older adults;M Mapstone;Nature medicine,2014